Literature DB >> 21928004

Absent skeletal uptake of (99m)Tc-hydroxymethylene diphosphonate in the presence of AL-type amyloidosis associated with multiple myeloma.

Tomoaki Sasaki1, Atsutaka Okizaki, Koji Takahashi, Masayuki Mineta, Kenichi Nagasawa, Yasuomi Fujimoto, Kyuhei Kohda, Tamio Aburano.   

Abstract

A 66-year-old woman with congestive heart failure suspected to have multiple myeloma underwent bone scintigraphy. The bone scintigraphy using technetium-99m hydroxymethylene-diphosphonate showed the following interesting findings: absent skeletal uptake; increased gastrointestinal, myocardial, and soft tissue uptake; migration of radionuclide to bilateral pleural effusions. Histopathological examination revealed that the patient suffered from AL-type amyloidosis associated with multiple myeloma. Extraosseous uptake is often observed on bone scintigraphy in amyloidosis patients, but in many cases skeletal uptake is preserved. The simultaneous presentation of these findings is rare.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21928004     DOI: 10.1007/s11604-011-0596-4

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  7 in total

Review 1.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

Review 2.  Methods for staining amyloid in tissues: a review.

Authors:  M T Elghetany; A Saleem
Journal:  Stain Technol       Date:  1988-07

3.  Soft-tissue uptake of technetium-99m MDP in multiple myeloma.

Authors:  T Kanoh; H Uchino; I Yamamoto; K Torizuka
Journal:  Clin Nucl Med       Date:  1986-12       Impact factor: 7.794

4.  Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals.

Authors:  D F Worsley; B C Lentle
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

5.  Extensive soft tissue uptake of 99Tcm methylene diphosphonate in a patient with multiple myeloma.

Authors:  J C Evans; M Murphy; B Eyes
Journal:  Br J Radiol       Date:  2000-09       Impact factor: 3.039

6.  Altered radiopharmaceutical distribution in myeloma: bone tracer in the heart and heart tracer in the bone.

Authors:  A K Gupta; P Meyer; M D Gross; L M Fig; B Shapiro
Journal:  Clin Nucl Med       Date:  1998-12       Impact factor: 7.794

7.  Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.

Authors:  P N Hawkins; J P Lavender; M B Pepys
Journal:  N Engl J Med       Date:  1990-08-23       Impact factor: 91.245

  7 in total
  1 in total

1.  Diffuse Myocardial Uptake of (99m)Tc-HDP in Multiple Myeloma.

Authors:  Koray Demirel; Murat Sadic; Meliha Korkmaz; Aylin Comak; Hasan Ikbal Atilgan; Gökhan Koca
Journal:  Nucl Med Mol Imaging       Date:  2013-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.